pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 2,216 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    hymenoptera venom allergen extract
    White Faced Hornet Hymenoptera Venom Multidose
    Allergies Jubilant HollisterStier LLC
  • Marketed
    hyoscine methobromide
    Methscopolamine Bromide (hyoscine methobromide [INN])
    Peptic Ulcers AACE Pharmaceuticals Inc
  • Marketed
    ibalizumab
    Trogarzo (ibalizumab-uiyk)
    Human Immunodeficiency Virus (HIV) Infections (AIDS) Theratechnologies Inc
← prev
page 54 of 74
next →
131
Pain89
Neurology1
Marketed
ibritumomab tiuxetan
Zevalin (ibritumomab tiuxetan)
B-Cell Non-Hodgkin Lymphoma
Acrotech Biopharma Inc
  • Marketed
    ibrutinib
    Imbruvica (ibrutinib)
    Follicular Lymphoma$ABBV AbbVie Inc.
  • Marketed
    ibuprofen lysine
    Neoprofen (ibuprofen lysine)
    Patent Ductus Arteriosus Recordati Rare Diseases Inc
  • Marketed
    ibutilide fumarate
    Ibutilide Fumarate
    Atrial Fibrillation American Regent Inc
  • Marketed
    icatibant acetate
    Firazyr (icatibant acetate)
    Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN… Takeda Pharmaceuticals USA Inc
  • Marketed
    icosapent ethyl
    Alfa (icosapent ethyl)
    Familial Adenomatous Polyposis KD Pharma Group SA
  • Marketed
    idarucizumab
    Praxbind (idarucizumab)
    Bleeding And Clotting Disorders Boehringer Ingelheim Corp
  • Marketed
    idecabtagene vicleucel
    Abecma (idecabtagene vicleucel)
    Refractory Multiple Myeloma Celgene Corp
  • Marketed
    idursulfase
    Elaprase (idursulfase)
    Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) Shire Human Genetic Therapies Inc
  • Marketed
    iloperidone
    Fanapt (iloperidone)
    Bipolar I Disorder$VNDA Vanda Pharmaceuticals Inc.
  • Marketed
    imipramine
    Imipramine Hydrochloride (imipramine [INN])
    Enuresis Oxford Pharmaceuticals LLC
  • Marketed
    inamrinone
    Amrinone Lactate (inamrinone)
    Congestive Heart Failure (Heart Failure) Hikma Pharmaceuticals USA Inc
  • Marketed
    incobotulinumtoxinA
    Xeomin (incobotulinumtoxinA)
    Sialorrhoea Merz Pharmaceuticals LLC
  • Marketed
    indapamide
    Indapamide
    Edema Rising Pharma Holdings Inc
  • Marketed
    indomethacin
    Indomethacin
    Acute and Sub-Acute Bursitis ACP Nimble Buyer Inc
  • Marketed
    indomethacin sodium
    Indomethacin Sodium
    Patent Ductus Arteriosus Hikma Pharmaceuticals USA Inc
  • Marketed
    inebilizumab
    Uplizna (inebilizumab)
    Immunoglobulin G4-Related Disease (IgG4-RD) Horizon Therapeutics USA Inc
  • Marketed
    infigratinib phosphate
    infigratinib phosphate
    Achondroplasia QED Therapeutics Inc
  • Marketed
    infliximab
    Remicade (infliximab)
    Plaque Psoriasis (Psoriasis Vulgaris) Janssen Biotech Inc
  • Marketed
    influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent) vaccine
    Flublok Quadrivalent
    Influenza A Virus, H1N1 Subtype Infections Sanofi Pasteur Inc
  • Marketed
    influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent, split virion) vaccine
    Flulaval Quadrivalent
    Influenza A Virus, H1N1 Subtype Infections GlaxoSmithKline Consumer Healthcare LP
  • Marketed
    influenza [strains A/H1N1 + A/H3N2 + B] (split virion) vaccine
    Fluzone
    Influenza A Virus, H1N1 Subtype Infections Sanofi Pasteur Inc
  • Marketed
    influenza [strains A/H1N1 + A/H3N2 + B] (trivalent) vaccine
    Flucelvax
    Influenza A Virus, H1N1 Subtype Infections Seqirus Ltd
  • Marketed
    influenza [strains A/H1N1 + A/H3N2 + B] (trivalent, split virion) vaccine
    Afluria
    Influenza A Virus, H1N1 Subtype Infections Seqirus Ltd
  • Marketed
    influenza [types A and B] (quadrivalent) vaccine
    Flucelvax Quadrivalent
    Influenza A Virus, H1N1 Subtype Infections Seqirus Ltd
  • Marketed
    inotuzumab ozogamicin
    Besponsa (inotuzumab ozogamicin)
    B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphobla…$PFE PFIZER INC
  • Marketed
    insulin degludec LA
    Tresiba (insulin degludec)
    Type 1 Diabetes (Juvenile Diabetes) Novo Nordisk Inc